RUBICON GENOMICS ADDS NEW DISTRIBUTORS AS PRODUCT SALES CONTINUED TO ACCELERATE IN 2015
January 11, 2016
Ann Arbor, MI –– Rubicon Genomics, Inc. today reported a 40% increase in year-over-year sales in 2015. Rubicon also announced the addition of new distributors in India and Poland. Rubicon is a leading provider of pre-analytical library preparation kits for the research market that increase the accuracy, efficiency and speed of routine genomic analysis. Rubicon’s [...]
Bio-Rad and Illumina to Co-Develop Comprehensive Solution for Single-Cell Genomics
January 11, 2016
HERCULES, Calif. & SAN DIEGO -- Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIOb) andIllumina, Inc. (NASDAQ: ILMN) today announced an exclusive partnership to develop the most comprehensive next-generation sequencing (NGS) workflow for single-cell analysis. The end-to-end commercial solution will enable high-throughput sequencing of thousands of individual cells, traditionally a challenging, costly and time-consuming process. Most [...]
January 11, 2016
SAN DIEGO, Calif. — Agena Bioscience today announced the expansion of its headquarters to a new site in San Diego. Located at 4755 Eastgate Mall, the new 55,000-square-foot facility houses the company’s laboratory, manufacturing, and office workforce. “We’re tremendously excited about moving our headquarters into a larger space. Not only will the new facility enable [...]
January 11, 2016
Mountain View, CA -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the launch of the Guide-it CRISPR/Cas9 Gesicle Production System. This system provides an innovative method to deliver Cas9/single guide RNA (sgRNA) ribonucleoprotein complexes to a broad range of cell types. "While CRISPR/Cas9 is a great enabling technique for genome [...]
TRANSGENOMIC ANNOUNCES PRIVATE PLACEMENT FINANCING
January 11, 2016
OMAHA, Neb. -- Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing precision medicine through advanced diagnostic tests and clinical and research services, today announced that it raised gross proceeds of approximately $2.2 million in a preferred stock and warrant private placement financing with existing investors Crede Capital Group, LLC and Third Security, LLC. Through [...]
Pacific Biosciences Provides Update on Launch of New Sequel System
January 11, 2016
MENLO PARK, Calif. -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a pioneer and leader in long-read sequencing using its Single Molecule, Real-Time (SMRT®) Technology, today announced progress demonstrating customer demand for the company's new Sequel™ System, which was launched in October 2015. During the fourth quarter of 2015, orders were received for 49 units of [...]
PositiveID Corporation Announces 2015 Highlights and 2016 Outlook
January 11, 2016
DELRAY BEACH, Fla. -- PositiveID Corporation (“PositiveID” or “Company”) (PSID), a life sciences company focused on detection and diagnostics, announced today a summary of 2015 highlights and its outlook for 2016 following two recent acquisitions. Highlights Acquired E-N-G Mobile Systems, Inc., a growing business focused on mobile biological and chemical labs, with strong market share [...]
Seahorse Bioscience XF Technology Reaches 500th Citation in Cancer Research
January 11, 2016
BILLERICA, Mass. -- Seahorse Bioscience, a part of Agilent Technologies and the leader in metabolic analyzers and assay kits for measuring cell metabolism, has reached its 500th citation in cancer research. Published in Scientific Reports, the paper hypothesizes that because aberrant activation of the PI3K/Akt/mTOR pathway is a common feature of acute myeloid leukemia (AML) [...]
METTLER TOLEDO Announces FastTrack™ UV/VIS Spectroscopy To Speed Up Measurements
January 11, 2016
Schwerzenbach, Switzerland - The new UV/VIS Excellence product portfolio includes four models that provide outstanding optical performance: UV5, UV7, UV5Bio and UV5Nano. The UV5 provides simplicity in UV/VIS spectroscopy with easy direct measurement applications. The UV7 performance complies with strict EU and US Pharmacopeia requirements and provides advanced automation possibilities. The UV5Bio is the ideal [...]
SomaLogic completes agreement with Bristol-Myers Squibb for expanded access to SOMAmer reagents
January 11, 2016
BOULDER, CO - SomaLogic, Inc., announced it has signed an agreement with the Bristol-Myers Squibb Company (BMY) to provide expanded access to its proprietary SOMAmer reagents. The agreement covers both the 1,310 reagents available in the current public version of the SOMAscan assay as well as custom SOMAmer reagents developed through SomaLogic's SOMAmer Discovery Service [...]

